Keyphrases
Direct Oral Anticoagulants
100%
Levetiracetam
100%
Pharmacovigilance
100%
Ischemic Stroke
42%
Reporting Odds Ratio
42%
Shrinkage Analysis
28%
Interaction Effect
14%
Confidence Interval
14%
Adverse Events
14%
Apixaban
14%
Dabigatran
14%
Rivaroxaban
14%
Carbamazepine
14%
Logistic Model
14%
Individual Risk
14%
Strong Signals
14%
Hemorrhagic Stroke
14%
Event Occurrence
14%
Drug Monitoring
14%
Stroke Event
14%
Monitoring Strategy
14%
Concomitant Use
14%
Anticoagulant Use
14%
Post-stroke Epilepsy
14%
Edoxaban
14%
Enzyme Inducer
14%
FAERS Database
14%
P-glycoprotein Induction
14%
Pharmacology, Toxicology and Pharmaceutical Science
Levetiracetam
100%
Pharmacovigilance
100%
Direct Oral Anticoagulant
100%
Brain Ischemia
42%
Adverse Event
14%
Brain Hemorrhage
14%
Therapeutic Drug Monitoring
14%
P-Glycoprotein
14%
Rivaroxaban
14%
Apixaban
14%
Carbamazepine
14%
Dabigatran
14%
Edoxaban
14%
Neuroscience
Antithrombotic
100%
Levetiracetam
100%
Brain Ischemia
42%
Cerebral Hemorrhage
14%
Carbamazepine
14%
ABC Transporter Subfamily B
14%
Apixaban
14%
Rivaroxaban
14%
Dabigatran
14%
Edoxaban
14%